Goodwin
Jacqueline Mercier
- Deals
- 3
- Latest
- Jul 2026
Firm
- Goodwin Law firm · 2026 · 3 deals
Often works with
- Catherine Magazu 2 deals together
- Robert Crawford 1 deal together
- Sophie McGrath 1 deal together
- Elizabeth Rhodes 1 deal together
- Tim Worden 1 deal together
- Brittany Morreale 1 deal together
- Dulcie Daly 1 deal together
- Saba Rais 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jul 2026 | Neurimmune's royalty interest in AstraZeneca's cliramitug | Neurimmune | Royalty Pharma | Asset sale | Legal adviser to Royalty Pharma (acquirer) | Announced | 250.0 | Pharma+1 | Royalty Pharma acquisition of Neurimmune's royalty interest in AstraZeneca's cliramitug |
| Jan 2026 | PTC Therapeutics' remaining royalty on Roche's Evrysdi | PTC Therapeutics | Royalty Pharma | Asset sale | Legal adviser to Royalty Pharma (acquirer) | Announced | 240.0 | Specialty finance and leasing+2 | Royalty Pharma acquisition of PTC Therapeutics' remaining royalty on Roche's Evrysdi |
| Jan 2026 | Dark Blue Therapeutics | – | Amgen | Acquisition | Legal adviser to Dark Blue Therapeutics (target) | Completed | 840.0 | Biotech+2 | Amgen acquisition of Dark Blue Therapeutics |
Deals where Jacqueline Mercier is named on the firm's deal team, by the firm or the press.